Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812129) titled 'Insulin Eye Drops and Epithelial Healing After Corneal Cross-linking' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Cairo University

Condition: Corneal Epithelial Wound Healing Post Operative Pain

Intervention: Drug: Insulin eye drops

Recruitment Status: Not recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: November 1, 2023

Target Sample Size: 24

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07812129

Publi...